Neurovirulence Test of Types 1, 2 or 3 Live attenuated Poliomyelitis vaccines (Oral) in Transgenic Mice susceptible to Poliovirus
Standard Operating Procedure, Version 8
26 November 2021
| Technical document
WHO Team
Norms and Standards for Biological Products (NSB)
Number of pages
41
Copyright
World Health Organization